ARK Genomic Revolution ETF vs Dropbox Inc — how do they compare? ARK Genomic Revolution ETF trades at $44.33, while Dropbox Inc trades at $33.6 (market cap $7.41B). Which is the better fit depends on your goals.
| ARKG | DBX | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $44.55 | $35.00 |
52-Week Low | $24.02 | $22.06 |
Market Cap | — | $7.41B |
Enterprise Value | — | $10.27B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Dropbox (DBX) trades at $33.68, down 2.63% on the day, yet maintains a bullish technical trend with consistent earnings beats in recent quarters. The company reported Q2 2026 EPS of $0.75, exceeding expectations of $0.74, driven by core file-sync-and-share growth and AI expansion. Despite a negative shareholder equity position, operating cash flow remains strong at $952 million for 2025, supporting ongoing business investments.
The outlook is cautiously optimistic, with raised 2026 guidance signaling management confidence, but high debt levels and competitive pressures in cloud storage pose risks. Analyst sentiment is mixed, with 37.5% recommending buy, highlighting potential upside if execution continues, though investors should weigh valuation against balance sheet concerns.
Trailing returns across standard periods
Latest headlines on both assets
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Dropbox is a leading provider of cloud-storage and content collaboration tools with an emphasis on individuals and SMB. The company was founded in 2007 and was a pioneer in cloud storage and cross-platform file syncing. Utilizing inorganic and organic means, the firm has been working on diversifying its product mix and pivoting away from the cloud-storage space.
Read more on DBX →